Skip to content

Tag: Patient access

Explore our medication guides and pharmacology articles within this category.

Is Orladeyo a Specialty Drug? Understanding Its Role and Patient Access

5 min read
According to several health insurance and pharmacy benefit managers, Orladeyo has been designated a specialty medication. For individuals with hereditary angioedema (HAE), understanding the classification of 'is orladeyo a specialty drug?' is crucial, as this designation significantly impacts the medication's cost, distribution, and the supportive services available to them.

Is there a generic Abraxane? Answering Your Top Questions

3 min read
Following the expiration of key patents and regulatory milestones, multiple generic versions of Abraxane (nab-paclitaxel) have entered the United States market since 2022. This development provides more affordable options for patients needing this crucial chemotherapy drug.